Filing Details
- Accession Number:
- 0001209191-23-014361
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-01 20:00:19
- Reporting Period:
- 2023-02-27
- Accepted Time:
- 2023-03-01 20:00:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1420800 | Enovis Corp | ENOV | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 541887631 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1625057 | L. Matthew Trerotola | 2711 Centerville Road Suite 400 Wilmington DE 19808 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2023-02-27 | 32,283 | $0.00 | 194,827 | No | 4 | A | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2023-02-27 | 18,917 | $56.21 | 175,910 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 | Acquisiton | 2023-02-28 | 28,221 | $0.00 | 204,131 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Employee Stock Option (right to buy) | Acquisiton | 2023-02-28 | 66,922 | $0.00 | 66,922 | $57.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 66,922 | 2030-02-27 | No | 4 | A | Direct |
Footnotes
- Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units.
- This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
- The option vests in three equal annual installments beginning on the first anniversary of the grant date.
Billionaire Hedge Funds
